Treatment of HIV-Associated Nephropathies
Links shared publicly online about this topic.
- 533total visits
Treatment of HIV-Associated Nephropathies
View full resource at content.karger.com
Tags: HIV, STD, Kidney Health, Urinary System, Kidney Disease, Chronic Kidney Disease, Nephropathy
Most Recently Shared on February 3, 2011 at 6:05 pm By:
Treatment of #HIV Associated Nephropathies. #kidney http://bit.ly/et0xCi
Better ways to predict kidney disease risk for African Americans: Gene testing could help identify patients who need early treatment
sciencedaily.com — “African Americans with certain gene variants develop non-diabetic kidney disease more often than expected. African Americans with these variants risk developing focal segmental glomerulosclerosis and HIV nephropathy in particular and may need dialysis at a young age. Screening for these variants could identify individuals who should receive kidney-protective treatments” View full resource at sciencedaily.com
Most Recently Shared on October 14, 2011 at 9:57 pm By:
Better ways to predict kidney disease risk for African Americans: Gene testing could help. http://t.co/amaFSjlU
Focal segmental glomerulosclerosis causes HIV nephropathy
kevinmd.com — “The most common cause of HIV-associated nephropathy is collapsing focal segmental glomerulosclerosis, which is characterized by massive proteinuria.” View full resource at kevinmd.com
Most Recently Shared on September 10, 2011 at 2:10 pm By:
MKSAP: 25-year-old man with swelling of the feet and legs http://t.co/Cp0D2Lq via @kevinmd
Growth Hormone Axis for HIV-associated Lipodystrophy - QualityPoint Technologies
qualitypointtech.net — “Are growth hormone axis treatments an effective treatment for HIV-associated lipodystrophy? HIV Medicine” View full resource at qualitypointtech.net
Most Recently Shared on August 30, 2011 at 9:00 pm By:
Growth Hormone Axis for HIV-associated Lipodystrophy: Are growth hormone axis treatments an effective treatment fo... http://t.co/nMODDyQ
South Africa could reduce HIV-associated costs, extend lives with earlier treatment, study says
news-medical.net — “If South Africa followed WHO recommendations for earlier therapy for people living with HIV, thousands of lives could be extended and the country would start saving money after 16 years, according to a study recently published online in PLoS One, United Press International reports.” View full resource at news-medical.net
Most Recently Shared on July 27, 2011 at 9:17 am By:
South Africa could reduce HIV-associated costs, extend lives with earlier treatment, study says: If South Africa... http://bit.ly/nMYJ4O
South Africa Could Reduce HIV-Associated Long-Term Costs, Extend Lives With Earlier Treatment, Study Says - The Body
thebody.com — “If South Africa followed WHO recommendations for earlier therapy for people living with HIV, thousands of lives could be extended and the country would ...” View full resource at thebody.com
Most Recently Shared on July 26, 2011 at 9:01 pm By:
South Africa Could Reduce HIV-Associated Long-Term Costs, Extend Lives With Earlier Treatment, Study Says http://bit.ly/oqaOG1 #aids
Ask the Doctor: What Is HIV-Associated Nephropathy, and How Can I Avoid It? - The Body
thebody.com — “Theresa Mack, M.D., M.P.H. Every month, HIV specialist Theresa Mack, M.D., M.P.H. -- an associate medical director at St. Luke's Roosevelt Morningside ...” View full resource at thebody.com
Most Recently Shared on July 5, 2011 at 8:01 pm By:
Ask the Doctor: What Is HIV-Associated Nephropathy, and How Can I Avoid It? http://bit.ly/mFycM5 #kidney #renal
Relypsa Begins Treatment In AMETHYST-DN Trial Of RLY5016 For Hyperkalemia In Diabetic Nephropathy Patients With Chronic Kidney Disease
medicalnewstoday.com — “Relypsa, Inc. today announced the start of dosing in a Phase 2b clinical trial of RLY5016 for the treatment of hyperkalemia in patients with diabetic nephropathy and chronic kidney disease (CKD).” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2011 at 12:05 pm By:
Relypsa Begins Treatment In AMETHYST-DN Trial Of RLY5016 For Hyperkalemia In Diabetic Nephropathy Patients With Chroni... http://mnt.to/3XNp
Study Identifies New Diabetic Kidney Disease Treatment
renalbusiness.com — “UC Davis investigators have shown that blocking a specific receptor pathway could slow or even prevent diabetic nephropathy an often fatal complication of diabetes for which there are few good treatment options, according to a study published online May 26 in Arteriosclerosis, Thrombosis and Vascular Biology.” View full resource at renalbusiness.com
Most Recently Shared on May 27, 2011 at 12:05 pm By:
The Kidney Group Nephrology and Physician Group
Study identifies new diabetic #kidney treatment. #diabetes http://ow.ly/541yI
Symposier - IgA Nephropathy - Mayo Clinic - New Treatment Option
symposier.com — “Uploaded and shared in Youtube by: mayoclinic --" Mayo Clinic' s Dr. Fernando Fervenza, M.D., Ph.D., discusses IgA nephropathy and a new treatment option for those with progressive nephropathy.” View full resource at symposier.com
Most Recently Shared on April 12, 2011 at 6:08 pm By:
Symposier Nephrology Nephrology and Health Business
Dr. Fernando Fervenza discusses IgA nephropathy and a new treatment option for those with progressive nephropathy. http://bit.ly/ewO58u
POZ - Treatment News : Brain Impairment Might Be Less Common in People With HIV Than Originally Suspected
poz.com — “People with HIV might be at much lower risk of brain impairment than a recent study suggested, according to two presentations at the 17th annual conference of the British HIV Association (BHIVA) held April 6 to 8 in Bournemouth, England. The results of the two new studies, reported by the website aidsmap, offer hope to people with HIV and demonstrate the need to understand why brain impairment rates have varied so widely in studies.” View full resource at poz.com
Most Recently Shared on April 12, 2011 at 12:03 am By:
POZ Newsfeed: Brain Impairment Might Be Less Common in People With HIV Than Originally Suspected http://bit.ly/eUe2M7 #HIV #Brain #AIDS
Concert Pharmaceuticals Advances Novel Chronic Kidney Disease Treatment, CTP-499, In Phase 1 Clinical Study
medicalnewstoday.com — “Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and ot” View full resource at medicalnewstoday.com
Most Recently Shared on March 30, 2011 at 6:05 pm By:
Concert Pharmaceuticals Advances Novel Chronic Kidney Disease Treatment, CTP-499, In Phase 1 Clinical Study http://mnt.to/3SWs #urology
YouTube - Membranous Nephropathy - Mayo Clinic
youtube.com — “Fernando Fervenza, M.D., Ph.D., a nephrologist at Mayo Clinic, discusses treatment options and clinical trials for Membranous Nephropathy. http://mayoresearc...” View full resource at youtube.com
Most Recently Shared on March 25, 2011 at 6:38 pm By:
Fernando Fervenza, M.D., Ph.D., discusses treatment options and clinical trials for Membranous Nephropathy. http://bit.ly/nephropathy
Endocrinology Article | Diabetic Nephropathies
mdlinx.com — “Evidence-based guideline: Treatment of painful diabetic neuropathy” View full resource at mdlinx.com
Most Recently Shared on March 11, 2011 at 11:33 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Evidence-based guideline: Treatment of painful diabetic neuropathy: Muscle & Nerve http://bit.ly/dOusI8 #endo
Medical News: ARB Averts Early Sign of Diabetic Nephropathy - in Nephrology, Diabetes from MedPage Today
medpagetoday.com — “Preemptive treatment with an angiotensin-receptor blocker (ARB) may delay onset of microalbuminuria in type 2 diabetes but with a concerning signal for cardiovascular death, a randomized trial showed.” View full resource at medpagetoday.com
Most Recently Shared on March 11, 2011 at 3:06 am By:
Yvo Sijpkens MD Doctor, Internist, Nephrologist, and Physician
ARB Averts Early Sign of Diabetic Nephropathy: http://bit.ly/fzerjs
Medical News: ARB Averts Early Sign of Diabetic Nephropathy - in Nephrology, Diabetes from MedPage Today
medpagetoday.com — “Preemptive treatment with an angiotensin-receptor blocker (ARB) may delay onset of microalbuminuria in type 2 diabetes but with a concerning signal for cardiovascular death, a randomized trial showed.” View full resource at medpagetoday.com
Most Recently Shared on March 10, 2011 at 4:42 pm By:
ARB Averts Early Sign of Diabetic Nephropathy (CME/CE) http://bit.ly/hUzDTG
Advertisement
